NIVABUPA Niva Bupa Health Insurance Company Q1 FY27 results (Apr–Jun 2026) and concall
Niva Bupa Health Insurance reported strong Q1 FY27 results, driven by robust retail health growth and improved profitability metrics. The company successfully transitioned to Ind AS and saw significant improvements in its combined insurance service ratio and retail loss ratio. While group business faced pricing challenges, strategic initiatives like the Preferred Provider Network and digital adoption continue to support overall performance and market share gains.
You’re reading a preview. Opening the full call uses 1 concall credit.
Sign in to use your monthly call allowance.
What they filed
Q1 FY27: revenue up 27.9%, net profit up 94.4% against the same quarter last year.
| Line item | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 | Q4 FY26 | Q1 FY27 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 1,321 | 1,258 | 1,671 | 1,932 | 1,574 +19% | 1,611 +28% | 2,251 +35% | 2,471 +28% |
| EBITDA | -66 | -24 | 251 | 98 | -53 +20% | -94 −292% | 182 −27% | 184 +88% |
| Net profit | 13 | 13 | 206 | 71 | -35 −369% | -88 −777% | 159 −23% | 138 +94% |
How to read this
₹ crore, as filed. The percentage beside a figure is the change against the same quarter a year earlier — never the quarter before, which would make every seasonal business look like it collapses and booms each year.
Inve summary of a publicly available earnings call transcript; see how call summaries are prepared. Not investment advice.
